» Articles » PMID: 27796514

Results of a Nation-wide Retrospective Study of Lymphadenectomy for Esophagogastric Junction Carcinoma

Overview
Journal Gastric Cancer
Date 2016 Nov 1
PMID 27796514
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Esophagogastric junction (EGJ) carcinoma has attracted considerable attention because of the marked increase in its incidence globally. However, the optimal extent of esophagogastric resection for this tumor entity remains highly controversial.

Methods: This was a questionnaire-based national retrospective study undertaken in an attempt to define the optimal extent of lymph node dissection for EGJ cancer. Data from patients with EGJ carcinoma, less than 40 mm in diameter, who underwent R0 resection between January 2001 and December 2010 were reviewed.

Results: Clinical records of 2807 patients without preoperative therapy were included in the analysis. There are distinct disparities in terms of the nodal dissection rate according to histology and the predominant tumor location. Nodal metastases frequently involved the abdominal nodes, especially those at the right and left cardia, lesser curvature and along the left gastric artery. Nodes along the distal portion of the stomach were much less often metastatic, and their dissection seemed unlikely to be beneficial. Lower mediastinal node dissection might contribute to improving survival for patients with esophagus-predominant EGJ cancer. However, due to low dissection rates for nodes of the middle and upper mediastinum, no conclusive result was obtained regarding the optimal extent of nodal dissection in this region.

Conclusions: Complete nodal clearance along the distal portion of the stomach offers marginal survival benefits for patients with EGJ cancers less than 4 cm in diameter. The optimal extent of esophageal resection and the benefits of mediastinal node dissection remain issues to be addressed in managing patients with esophagus-predominant EGJ cancers.

Citing Articles

Comparative study of clinical efficacy of laparoscopic proximal gastrectomy with double-channel anastomosis and tubular gastroesophageal anastomosis.

Wang M, Zhang L, Wang G, Miao Y, Zhang T, Qiu L World J Gastrointest Surg. 2025; 17(1):101204.

PMID: 39872779 PMC: 11757183. DOI: 10.4240/wjgs.v17.i1.101204.


y-shaped side overlap esophagogastrostomy in proximal gastrectomy.

Kurokawa Y, Saito T, Yamamoto K, Takahashi T, Doki Y Ann Gastroenterol Surg. 2025; 9(1):205-210.

PMID: 39759978 PMC: 11693538. DOI: 10.1002/ags3.12859.


Remnant Stomach Influx Reduces Esophageal Reflux and Malnutrition After Proximal Gastrectomy With Double Tract Reconstruction.

Nishiguchi R, Shimakawa T, Asaka S, Ogawa M, Yamaguchi K, Murayama M Cancer Diagn Progn. 2025; 5(1):62-71.

PMID: 39758241 PMC: 11696333. DOI: 10.21873/cdp.10413.


Esophago-jejunal anastomosis with open approach using the parachute technique to prioritize safety after resection of esophagogastric junction cancer.

Higuchi T, Niihara M, Minoura H, Harada H, Chuman M, Washio M Langenbecks Arch Surg. 2024; 409(1):364.

PMID: 39607596 DOI: 10.1007/s00423-024-03535-1.


The impact of histological subtype on postoperative recurrence pattern and timing in locally advanced esophagogastric junction cancer.

Maeda S, Ota M, Ito S, Hosoda K Discov Oncol. 2024; 15(1):466.

PMID: 39299945 PMC: 11413267. DOI: 10.1007/s12672-024-01353-x.


References
1.
Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T . Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. Ann Surg. 2016; 265(2):277-283. DOI: 10.1097/SLA.0000000000001814. View

2.
Takeuchi H, Fujii H, Ando N, Ozawa S, Saikawa Y, Suda K . Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg. 2009; 249(5):757-63. DOI: 10.1097/SLA.0b013e3181a38e89. View

3.
Dikken J, Lemmens V, Wouters M, Wijnhoven B, Siersema P, Nieuwenhuijzen G . Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer. 2012; 48(11):1624-32. DOI: 10.1016/j.ejca.2012.01.009. View

4.
Matsuda T, Kurokawa Y, Yoshikawa T, Kishi K, Misawa K, Ohi M . Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study. World J Surg. 2016; 40(7):1672-9. DOI: 10.1007/s00268-016-3451-z. View

5.
Mine S, Sano T, Hiki N, Yamada K, Nunobe S, Yamaguchi T . Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction. Br J Surg. 2012; 100(2):261-6. DOI: 10.1002/bjs.8967. View